Loading...
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
BACKGROUND: HER2 mutation has been found to be an oncogenic driver gene in non-small cell lung cancers(NSCLC) and HER2-directed therapies have shown promising results in this unique population, while little is known about its association with outcomes of chemotherapy. The aim of this study was to in...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5869778/ https://ncbi.nlm.nih.gov/pubmed/29587667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4277-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|